G1 Therapeutics - 53 Year Dividend History | GTHX
Historical dividend payout and yield for G1 Therapeutics (GTHX) since 1971. The current TTM dividend payout for G1 Therapeutics (GTHX) as of April 15, 2024 is $0.00. The current dividend yield for G1 Therapeutics as of April 15, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.238B |
$0.083B |
|
G1 Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It engaged in developing novel, small-molecule therapies which address significant unmet needs in the treatment of cancer. The company's product pipeline consists of CDK4/6, Trilaciclib (G1T28), G1T38 and G1T48. G1 Therapeutics, Inc. is based in Research Triangle Park, NC.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
